Elevated Pre-HSCT Ferritin is Not Associated with Increased Risk of Acute Graft Versus Host Disease in Patients with High Risk Sickle Cell Disease Undergoing Haploidentical T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT)

Authors

Yara Perez
Liana Klejmont, New York Medical CollegeFollow
Harshini Mahanti, New York Medical College
Jessica Hochberg, New York Medical CollegeFollow
Allyson Flower, New York Medical CollegeFollow
Qiuhu Shi, New York Medical CollegeFollow
Theodore B. Moore
Julie-An Talano
Shalini Shenoy
Erin Morris
Mitchell S. Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

3-2018

Journal Title

Biology of Blood and Marrow Transplantation

Department

Medicine

Second Department

Pediatrics

Third Department

Public Health

Disciplines

Medicine and Health Sciences

Recommended Citation

Perez, Y., Klejmont, L., Mahanti, H., Hochberg, J., Flower, A., Shi, Q., Moore, T. B., Talano, J., Shenoy, S., Morris, E., & Cairo, M. S. (2018). Elevated Pre-HSCT Ferritin is Not Associated with Increased Risk of Acute Graft Versus Host Disease in Patients with High Risk Sickle Cell Disease Undergoing Haploidentical T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT). Biology of Blood and Marrow Transplantation, 24 (3 Suppl.1), S205. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/360